Erbulozole Explained

Erbulozole (R55104) is a congener of the microtubule inhibitor tubulozole. It is undergoing phase I clinical trials as a chemotherapeutic agent.^[1]

Other reading

• Distelmans W, VanGinckel P, Heeres J, Van der Veken LJ . Erbulozole. Antineoplastic, Microtubule inhibitor. Drugs Future . 1991 . 16 . 6 . 577.

Notes and References

1. Van Belle SJ, Distelmans W, Vandebroek J, Bruynseels J, Van Ginckel R, Storme GA . Phase I trial of erbulozole (R55104) . Anticancer Research . 13 . 6B . 2389–91 . 1993 . 8135472 .